Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darapladib in Carotid Plaque Composition
NCT01916720Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2003
- Primary completion
- Jul 2003
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of darapladib in atherosclerosis, carotid artery disease, sponsored by GSK. Started Jan 2003; status: completed.
02
Drugs
darapladib
03
Conditions
atherosclerosiscarotid artery disease
Beyond the preview
Go deeper on NCT01916720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01916720.